peptide,lca,superkingdom,kingdom,subkingdom,superphylum,phylum,subphylum,superclass,class,subclass,infraclass,superorder,order,suborder,infraorder,parvorder,superfamily,family,subfamily,tribe,subtribe,genus,subgenus,species group,species subgroup,species,subspecies,varietas,forma,EC,EC - names,GO (cellular component),GO (molecular function),GO (biological process),GO (cellular component) - names,GO (molecular function) - names,GO (biological process) - names,InterPro,InterPro - names
YLYELAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.35 (57%);2.5.1.7 (14%);2.7.13.3 (14%),Pyridoxal kinase (57%);UDP-N-acetylglucosamine 1-carboxyvinyltransferase (14%);Histidine kinase (14%),GO:0005615 (86%);GO:0005737 (19%);GO:0032991 (9%),extracellular space (86%);cytoplasm (19%);protein-containing complex (9%),GO:0046872 (43%);GO:0005504 (14%);GO:0003677 (9%),metal ion binding (43%);fatty acid binding (14%);DNA binding (9%),GO:0001542 (13%);GO:0042448 (13%);GO:0060395 (13%),ovulation from ovarian follicle (13%);progesterone metabolic process (13%);SMAD protein signal transduction (13%),IPR000264 (90%);IPR014760 (90%);IPR020858 (90%),ALB/AFP/VDB (90%);Serum albumin, N-terminal (90%);Serum albumin-like (90%)
LSSPATLNSR,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (11%);GO:0016021 (2%),extracellular space (11%);integral component of membrane (2%),GO:0004252 (100%);GO:0046872 (4%),serine-type endopeptidase activity (100%);metal ion binding (4%),GO:0006508 (11%);GO:0007586 (4%),proteolysis (11%);digestion (4%),IPR001254 (100%);IPR009003 (100%);IPR043504 (100%),Serine proteases, trypsin domain (100%);Peptidase S1, PA clan (100%);Peptidase S1, PA clan, chymotrypsin-like fold (100%)
LSSPATLDSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LATVLSPR,Gammaproteobacteria,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR002634 (100%);IPR036065 (100%),BolA protein (100%);BolA-like superfamily (100%)
SSPATLNDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VATVSPLR,Solirubrobacteraceae,Bacteria,,,,Actinobacteria,,,Thermoleophilia,,,Solirubrobacterales,,,,Solirubrobacteraceae,,,,,,,,,,,,,,,,GO:0005886 (100%);GO:0016021 (100%),plasma membrane (100%);integral component of membrane (100%),,,,,IPR003838 (100%);IPR025857 (100%),ABC3 transporter permease protein domain (100%);MacB-like periplasmic core domain (100%)
LSSLSVAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.3.1 (75%);2.7.9.2 (25%),Sarcosine oxidase (75%);Pyruvate, water dikinase (25%),GO:0005737 (60%);GO:0031463 (20%),cytoplasm (60%);Cul3-RING ubiquitin ligase complex (20%),GO:0008115 (60%);GO:0005524 (20%);GO:0008986 (20%),sarcosine oxidase activity (60%);ATP binding (20%);pyruvate, water dikinase activity (20%),GO:0046653 (60%);GO:0006090 (20%);GO:0006094 (20%),tetrahydrofolate metabolic process (60%);pyruvate metabolic process (20%);gluconeogenesis (20%),IPR006222 (50%);IPR006277 (50%);IPR013977 (50%),Aminomethyltransferase, folate-binding domain (50%);Sarcosine oxidase, alpha subunit (50%);Glycine cleavage T-protein, C-terminal barrel domain (50%)
VVTVLSPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0007165 (100%),signal transduction (100%),IPR000157 (100%);IPR035897 (100%),Toll/interleukin-1 receptor homology (TIR) domain (100%);Toll/interleukin-1 receptor homology (TIR) domain superfamily (100%)
ELYLSWVVEAR,Sarcopterygii,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,,,,,,,,,,,,,,,,,,,,,,1.6.2.4 (100%),NADPH--hemoprotein reductase (100%),GO:0016021 (90%);GO:0005789 (76%);GO:0005783 (8%),integral component of membrane (90%);endoplasmic reticulum membrane (76%);endoplasmic reticulum (8%),GO:0010181 (95%);GO:0003958 (88%);GO:0050660 (76%),FMN binding (95%);NADPH-hemoprotein reductase activity (88%);flavin adenine dinucleotide binding (76%),GO:0009725 (5%);GO:0003420 (2%);GO:0007584 (2%),response to hormone (5%);regulation of growth plate cartilage chondrocyte proliferation (2%);response to nutrient (2%),IPR003097 (100%);IPR017938 (100%);IPR023173 (100%),Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding (100%);Riboflavin synthase-like beta-barrel (100%);NADPH-cytochrome p450 reductase, FAD-binding, alpha-helical domain superfamily (100%)
TVMVEVTK,Sphingomonadaceae,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,Sphingomonadales,,,,Sphingomonadaceae,,,,,,,,,,,,,,,,GO:0009279 (100%),cell outer membrane (100%),,,,,IPR000531 (100%);IPR012910 (100%);IPR036942 (100%),TonB-dependent receptor-like, beta-barrel (100%);TonB-dependent receptor, plug domain (100%);TonB-dependent receptor-like, beta-barrel domain superfamily (100%)
LSGSVGNTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QEFLNAAK,Phorcysia thermohydrogeniphila,Bacteria,,,,Aquificae,,,Aquificae,,,Desulfurobacteriales,,,,Desulfurobacteriaceae,,,,Phorcysia,,,,Phorcysia thermohydrogeniphila,,,,,,,,,,GO:0009055 (100%);GO:0020037 (100%);GO:0046872 (100%),electron transfer activity (100%);heme binding (100%);metal ion binding (100%),,,IPR009056 (100%),Cytochrome c-like domain (100%)
FLVNLNMMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GNQQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLLSGWGAATK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DGALTQLNVAFSR,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,1.6.2.4 (100%),NADPH--hemoprotein reductase (100%),GO:0016021 (90%);GO:0005789 (80%);GO:0005783 (9%),integral component of membrane (90%);endoplasmic reticulum membrane (80%);endoplasmic reticulum (9%),GO:0010181 (92%);GO:0003958 (90%);GO:0050660 (79%),FMN binding (92%);NADPH-hemoprotein reductase activity (90%);flavin adenine dinucleotide binding (79%),GO:0009725 (8%);GO:0003420 (3%);GO:0007584 (3%),response to hormone (8%);regulation of growth plate cartilage chondrocyte proliferation (3%);response to nutrient (3%),IPR001433 (100%);IPR001709 (100%);IPR003097 (100%),Oxidoreductase FAD/NAD(P)-binding (100%);Flavoprotein pyridine nucleotide cytochrome reductase (100%);Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding (100%)
SLVNLGGSK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (100%);GO:0005886 (61%);GO:0001533 (33%),keratin filament (100%);plasma membrane (61%);cornified envelope (33%),GO:0046982 (35%);GO:0030246 (33%);GO:0030280 (33%),protein heterodimerization activity (35%);carbohydrate binding (33%);structural constituent of skin epidermis (33%),GO:0051290 (35%);GO:0001867 (33%);GO:0018149 (33%),protein heterotetramerization (35%);complement activation, lectin pathway (33%);peptide cross-linking (33%),IPR003054 (100%);IPR032444 (100%);IPR039008 (100%),Keratin, type II (100%);Keratin type II head (100%);Intermediate filament, rod domain (100%)
YYTLEELQK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (74%);GO:0005783 (29%);GO:0005829 (18%),integral component of membrane (74%);endoplasmic reticulum (29%);cytosol (18%),GO:0020037 (97%);GO:0046872 (97%);GO:0019899 (18%),heme binding (97%);metal ion binding (97%);enzyme binding (18%),GO:0046686 (3%);GO:0006631 (1%);GO:0019852 (1%),response to cadmium ion (3%);fatty acid metabolic process (1%);L-ascorbic acid metabolic process (1%),IPR001199 (100%);IPR036400 (100%);IPR018506 (95%),Cytochrome b5-like heme/steroid binding domain (100%);Cytochrome b5-like heme/steroid binding domain superfamily (100%);Cytochrome b5, heme-binding site (95%)
APVLSDSSCK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (33%),extracellular space (33%),GO:0004252 (100%);GO:0046872 (17%),serine-type endopeptidase activity (100%);metal ion binding (17%),GO:0006508 (33%);GO:0007586 (17%),proteolysis (33%);digestion (17%),IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
MDLGFSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.42 (50%);3.4.11.5 (50%),Branched-chain-amino-acid transaminase (50%);Prolyl aminopeptidase (50%),GO:0005634 (36%);GO:0016021 (18%);GO:0005886 (9%),nucleus (36%);integral component of membrane (18%);plasma membrane (9%),GO:0003677 (55%);GO:0000981 (18%);GO:0004177 (9%),DNA binding (55%);DNA-binding transcription factor activity, RNA polymerase II-specific (18%);aminopeptidase activity (9%),GO:0000160 (18%);GO:0006355 (18%);GO:0009097 (9%),phosphorelay signal transduction system (18%);regulation of transcription, DNA-templated (18%);isoleucine biosynthetic process (9%),IPR001356 (33%);IPR009057 (25%);IPR000047 (17%),Homeobox domain (33%);Homeobox-like domain superfamily (25%);Helix-turn-helix motif (17%)
MHFPHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVLDAAHPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPATLNDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVLNAAYVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLEGNEQFLNAAK,Simiiformes,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (15%);GO:0005576 (4%);GO:1904724 (4%),extracellular space (15%);extracellular region (4%);tertiary granule lumen (4%),GO:0004252 (100%);GO:0005509 (12%);GO:0008236 (4%),serine-type endopeptidase activity (100%);calcium ion binding (12%);serine-type peptidase activity (4%),GO:0006508 (12%);GO:0031638 (12%);GO:0043542 (12%),proteolysis (12%);zymogen activation (12%);endothelial cell migration (12%),IPR001254 (100%);IPR009003 (100%);IPR043504 (100%),Serine proteases, trypsin domain (100%);Peptidase S1, PA clan (100%);Peptidase S1, PA clan, chymotrypsin-like fold (100%)
HMFPHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHVELLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (14%);GO:0000439 (5%);GO:0016021 (5%),cytoplasm (14%);transcription factor TFIIH core complex (5%);integral component of membrane (5%),GO:0004843 (62%);GO:0003676 (14%);GO:0016740 (10%),thiol-dependent deubiquitinase (62%);nucleic acid binding (14%);transferase activity (10%),GO:0016579 (62%);GO:0006511 (52%);GO:0015074 (14%),protein deubiquitination (62%);ubiquitin-dependent protein catabolic process (52%);DNA integration (14%),IPR001394 (48%);IPR038765 (48%);IPR018200 (41%),Peptidase C19, ubiquitin carboxyl-terminal hydrolase (48%);Papain-like cysteine peptidase superfamily (48%);Ubiquitin specific protease, conserved site (41%)
VPGVSLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSSPATEVDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVNELHWPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CEEAAATK,Lingulodinium polyedra,Eukaryota,,,,,,,Dinophyceae,,,Gonyaulacales,,,,,,,,Lingulodinium,,,,Lingulodinium polyedra,,,,,,,,,,,,,,IPR000048 (100%),IQ motif, EF-hand binding site (100%)
EENALYSSLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QFLNAAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.1.7 (50%);6.2.1.13 (50%),Cysteine desulfurase (50%);Acetate--CoA ligase (ADP-forming) (50%),GO:0016021 (22%);GO:0005886 (11%),integral component of membrane (22%);plasma membrane (11%),GO:0016616 (33%);GO:0051287 (33%);GO:0003677 (11%),oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (33%);NAD binding (33%);DNA binding (11%),GO:0006310 (11%);GO:0006534 (11%);GO:0015074 (11%),DNA recombination (11%);cysteine metabolic process (11%);DNA integration (11%),IPR000014 (33%);IPR000160 (33%);IPR000700 (33%),PAS domain (33%);GGDEF domain (33%);PAS-associated, C-terminal (33%)
VATVNPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DMLGAYK,Eubacteriales,Bacteria,,,,Firmicutes,,,Clostridia,,,Eubacteriales,,,,,,,,,,,,,,,,,,5.3.1.9 (100%),Glucose-6-phosphate isomerase (100%),GO:0005737 (100%),cytoplasm (100%),GO:0004347 (100%),glucose-6-phosphate isomerase activity (100%),GO:0006094 (100%);GO:0006096 (100%),gluconeogenesis (100%);glycolytic process (100%),IPR010551 (100%);IPR011051 (100%);IPR014710 (100%),Glucose-6-phosphate isomerase, prokaryote (100%);RmlC-like cupin domain superfamily (100%);RmlC-like jelly roll fold (100%)
HMLMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHMLHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CGTLVDLNFDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSLSPTFNMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYMLPAQNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHHLSWVEVVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELYLSWVNLAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHLMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HMPMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NAALSGWNGTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CEWGALYSLSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VATVSSHAYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYYHLTASK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FHPMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LALHFNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.2.4 (100%),AMP nucleosidase (100%),GO:0005737 (20%);GO:0005874 (20%);GO:0030286 (20%),cytoplasm (20%);microtubule (20%);dynein complex (20%),GO:0005524 (30%);GO:0016491 (30%);GO:0003677 (20%),ATP binding (30%);oxidoreductase activity (30%);DNA binding (20%),GO:0007018 (20%),microtubule-based movement (20%),IPR002838 (27%);IPR016031 (27%);IPR036983 (27%),Mitochondrial biogenesis protein AIM24 (27%);Tryptophan RNA-binding attenuator protein-like domain superfamily (27%);Mitochondrial biogenesis AIM24 superfamily (27%)
HFPMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AVNYLVDLCK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QLMALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (54%);6.1.1.2 (11%);3.1.4.12 (6%),DNA-directed RNA polymerase (54%);Tryptophan--tRNA ligase (11%);Sphingomyelin phosphodiesterase (6%),GO:0016021 (13%);GO:0005737 (6%);GO:0005576 (3%),integral component of membrane (13%);cytoplasm (6%);extracellular region (3%),GO:0005524 (21%);GO:0003677 (20%);GO:0003899 (13%),ATP binding (21%);DNA binding (20%);DNA-directed 5'-3' RNA polymerase activity (13%),GO:0006351 (13%);GO:0009432 (4%);GO:0006417 (2%),transcription, DNA-templated (13%);SOS response (4%);regulation of translation (2%),IPR027417 (18%);IPR007293 (12%);IPR024952 (12%),P-loop containing nucleoside triphosphate hydrolase (18%);Flagellar protein FlgP (12%);Lipoprotein LPP20-like (12%)
MHLMHLTEER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RPNWAMHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HLYPGPDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CLLSENNSVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
APTPATLGSGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYYHLTTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVTVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005524 (100%);GO:0008134 (100%);GO:0043565 (100%),ATP binding (100%);transcription factor binding (100%);sequence-specific DNA binding (100%),GO:0000160 (100%);GO:0006355 (100%),phosphorelay signal transduction system (100%);regulation of transcription, DNA-templated (100%),IPR001789 (100%);IPR002078 (100%);IPR002197 (100%),Signal transduction response regulator, receiver domain (100%);RNA polymerase sigma factor 54 interaction domain (100%);DNA binding HTH domain,  Fis-type (100%)
VTVNLGGSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPATLNSR,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,,,GO:0004252 (100%),serine-type endopeptidase activity (100%),,,IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
MVDLAAVYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VATCFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.52 (100%),Beta-N-acetylhexosaminidase (100%),GO:0005615 (60%);GO:0005829 (10%);GO:0043231 (10%),extracellular space (60%);cytosol (10%);intracellular membrane-bounded organelle (10%),GO:0004867 (60%);GO:0004563 (10%);GO:0102148 (10%),serine-type endopeptidase inhibitor activity (60%);beta-N-acetylhexosaminidase activity (10%);N-acetyl-beta-D-galactosaminidase activity (10%),GO:0005975 (10%);GO:0016036 (10%);GO:0016567 (10%),carbohydrate metabolic process (10%);cellular response to phosphate starvation (10%);protein ubiquitination (10%),IPR013783 (70%);IPR014756 (70%);IPR001599 (60%),Immunoglobulin-like fold (70%);Immunoglobulin E-set (70%);Alpha-2-macroglobulin (60%)
YLYGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.11.2 (26%);3.4.21.89 (13%);3.6.4.12 (5%),Membrane alanyl aminopeptidase (26%);Signal peptidase I (13%);DNA helicase (5%),GO:0016021 (32%);GO:0005886 (8%);GO:0005615 (5%),integral component of membrane (32%);plasma membrane (8%);extracellular space (5%),GO:0005524 (13%);GO:0008270 (10%);GO:0003677 (8%),ATP binding (13%);zinc ion binding (10%);DNA binding (8%),GO:0006956 (6%);GO:0006310 (3%);GO:0006954 (3%),complement activation (6%);DNA recombination (3%);inflammatory response (3%),IPR027417 (10%);IPR013783 (6%);IPR014782 (6%),P-loop containing nucleoside triphosphate hydrolase (10%);Immunoglobulin-like fold (6%);Peptidase M1, membrane alanine aminopeptidase (6%)
VGPVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,GO:0051301 (80%),cell division (80%),IPR001182 (100%),Probable peptidoglycan glycosyltransferase FtsW/RodA (100%)
LVNELYTSPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DMLGYAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.205 (100%),IMP dehydrogenase (100%),GO:0005840 (71%);GO:0016021 (14%);GO:0005737 (7%),ribosome (71%);integral component of membrane (14%);cytoplasm (7%),GO:0003735 (71%);GO:0019843 (71%);GO:0000166 (7%),structural constituent of ribosome (71%);rRNA binding (71%);nucleotide binding (7%),GO:0006412 (71%);GO:0006177 (7%);GO:0006313 (7%),translation (71%);GMP biosynthetic process (7%);transposition, DNA-mediated (7%),IPR000876 (71%);IPR002942 (71%);IPR013843 (71%),Ribosomal protein S4e (71%);RNA-binding S4 domain (71%);Ribosomal protein S4e, N-terminal (71%)
SSPATVNEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MCNLSGDAGAATK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CPATK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.-.- (21%);4.2.99.18 (21%);2.3.2.27 (13%),Acting on the CH-CH group of donors (21%);DNA-(apurinic or apyrimidinic site) lyase (21%);RING-type E3 ubiquitin transferase (13%),GO:0005634 (32%);GO:0016021 (20%);GO:0005737 (4%),nucleus (32%);integral component of membrane (20%);cytoplasm (4%),GO:0043565 (29%);GO:0003700 (29%);GO:0016787 (9%),sequence-specific DNA binding (29%);DNA-binding transcription factor activity (29%);hydrolase activity (9%),GO:0006284 (4%);GO:0006650 (4%);GO:0008654 (4%),base-excision repair (4%);glycerophospholipid metabolic process (4%);phospholipid biosynthetic process (4%),IPR003657 (24%);IPR036576 (24%);IPR000675 (7%),WRKY domain (24%);WRKY domain superfamily (24%);Cutinase/acetylxylan esterase (7%)
FLVNLDFNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AMPLVGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.2.1.7 (100%),1-deoxy-D-xylulose-5-phosphate synthase (100%),GO:0016021 (17%),integral component of membrane (17%),GO:0016740 (33%);GO:0000287 (17%);GO:0003676 (17%),transferase activity (33%);magnesium ion binding (17%);nucleic acid binding (17%),GO:0009228 (17%);GO:0016114 (17%);GO:0052865 (17%),thiamine biosynthetic process (17%);terpenoid biosynthetic process (17%);1-deoxy-D-xylulose 5-phosphate biosynthetic process (17%),IPR026590 (33%);IPR029035 (33%);IPR000014 (17%),Sirtuin family, catalytic core domain (33%);DHS-like NAD/FAD-binding domain superfamily (33%);PAS domain (17%)
TLAMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.24.- (15%);7.3.2.2 (9%);2.7.1.23 (4%),Metalloendopeptidases (15%);ABC-type phosphonate transporter (9%);NAD(+) kinase (4%),GO:0016021 (28%);GO:0005886 (14%);GO:0005737 (11%),integral component of membrane (28%);plasma membrane (14%);cytoplasm (11%),GO:0005524 (22%);GO:0008270 (8%);GO:0003677 (8%),ATP binding (22%);zinc ion binding (8%);DNA binding (8%),GO:0030163 (4%);GO:0007165 (4%);GO:0051301 (3%),protein catabolic process (4%);signal transduction (4%);cell division (3%),IPR027417 (17%);IPR003593 (10%);IPR035965 (5%),P-loop containing nucleoside triphosphate hydrolase (17%);AAA+ ATPase domain (10%);PAS domain superfamily (5%)
MLVDLGPSYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QAPDTHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GNPDEHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HLVMKPYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
KPMHLDFPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QPMHLTATNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYYHLTANTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YLWAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.17.4.1 (14%);4.2.3.3 (14%);2.7.11.1 (10%),Ribonucleoside-diphosphate reductase (14%);Methylglyoxal synthase (14%);Non-specific serine/threonine protein kinase (10%),GO:0016021 (49%);GO:0005886 (10%);GO:0005887 (5%),integral component of membrane (49%);plasma membrane (10%);integral component of plasma membrane (5%),GO:0003677 (10%);GO:0020037 (10%);GO:0005524 (7%),DNA binding (10%);heme binding (10%);ATP binding (7%),GO:0017004 (8%);GO:1990397 (5%);GO:0055085 (5%),cytochrome complex assembly (8%);queuosine salvage (5%);transmembrane transport (5%),IPR002035 (19%);IPR036465 (19%);IPR013694 (18%),von Willebrand factor, type A (19%);von Willebrand factor A-like domain superfamily (19%);VIT domain (18%)
WYYHLTAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYYHLTAQSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QPMHLTEER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
KPMHLFDPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHLMHLTAQSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YWYHLTATNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GSGGGSSGGSLGGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (100%);GO:0005886 (53%);GO:0001533 (44%),keratin filament (100%);plasma membrane (53%);cornified envelope (44%),GO:0046982 (47%);GO:0030246 (44%);GO:0030280 (44%),protein heterodimerization activity (47%);carbohydrate binding (44%);structural constituent of skin epidermis (44%),GO:0050728 (47%);GO:0051290 (47%);GO:0061436 (47%),negative regulation of inflammatory response (47%);protein heterotetramerization (47%);establishment of skin barrier (47%),IPR032449 (100%);IPR003054 (97%);IPR039008 (97%),Keratin type II cytoskeletal 1, tail (100%);Keratin, type II (97%);Intermediate filament, rod domain (97%)
EQAGGDATENFEDVGHSTDAR,Sarcopterygii,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (80%);GO:0005783 (26%);GO:0005829 (17%),integral component of membrane (80%);endoplasmic reticulum (26%);cytosol (17%),GO:0020037 (82%);GO:0046872 (82%);GO:0019899 (17%),heme binding (82%);metal ion binding (82%);enzyme binding (17%),GO:0046686 (2%);GO:0006631 (0%);GO:0019852 (0%),response to cadmium ion (2%);fatty acid metabolic process (0%);L-ascorbic acid metabolic process (0%),IPR001199 (100%);IPR036400 (100%);IPR018506 (81%),Cytochrome b5-like heme/steroid binding domain (100%);Cytochrome b5-like heme/steroid binding domain superfamily (100%);Cytochrome b5, heme-binding site (81%)
VPQVSTPTLVEVSR,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0005615 (83%);GO:0005783 (22%);GO:0005794 (22%),extracellular space (83%);endoplasmic reticulum (22%);Golgi apparatus (22%),GO:0046872 (55%);GO:1903981 (21%);GO:0003677 (20%),metal ion binding (55%);enterobactin binding (21%);DNA binding (20%),GO:0009267 (20%);GO:0043066 (20%);GO:0051659 (20%),cellular response to starvation (20%);negative regulation of apoptotic process (20%);maintenance of mitochondrion location (20%),IPR000264 (100%);IPR014760 (100%);IPR020858 (100%),ALB/AFP/VDB (100%);Serum albumin, N-terminal (100%);Serum albumin-like (100%)
GNEQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VATVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (29%),extracellular space (29%),GO:0004252 (100%);GO:0046872 (14%),serine-type endopeptidase activity (100%);metal ion binding (14%),GO:0006508 (29%);GO:0007586 (14%),proteolysis (29%);digestion (14%),IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
LVNELTEFAK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0005615 (88%);GO:0032991 (17%);GO:0005783 (13%),extracellular space (88%);protein-containing complex (17%);endoplasmic reticulum (13%),GO:0046872 (71%);GO:0003677 (17%);GO:0005504 (17%),metal ion binding (71%);DNA binding (17%);fatty acid binding (17%),GO:0009267 (17%);GO:0043066 (17%);GO:0051659 (17%),cellular response to starvation (17%);negative regulation of apoptotic process (17%);maintenance of mitochondrion location (17%),IPR000264 (100%);IPR014760 (100%);IPR020858 (100%),ALB/AFP/VDB (100%);Serum albumin, N-terminal (100%);Serum albumin-like (100%)
LGEHNLDVLEGN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WLQQTLAAN,Simiiformes,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,,,,,,,,,,,,,,,,,,GO:0005615 (8%),extracellular space (8%),GO:0004252 (100%),serine-type endopeptidase activity (100%),GO:0006508 (8%),proteolysis (8%),IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
SLSLSVAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.5.1 (50%);3.5.99.2 (50%),Electron-transferring-flavoprotein dehydrogenase (50%);Aminopyrimidine aminohydrolase (50%),GO:0045095 (92%);GO:0005886 (47%);GO:0001533 (37%),keratin filament (92%);plasma membrane (47%);cornified envelope (37%),GO:0030280 (37%);GO:0046982 (36%);GO:0030246 (35%),structural constituent of skin epidermis (37%);protein heterodimerization activity (36%);carbohydrate binding (35%),GO:0018149 (37%);GO:0051290 (36%);GO:0001867 (35%),peptide cross-linking (37%);protein heterotetramerization (36%);complement activation, lectin pathway (35%),IPR032444 (92%);IPR003054 (91%);IPR039008 (91%),Keratin type II head (92%);Keratin, type II (91%);Intermediate filament, rod domain (91%)
LLTHPNFN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVTLVSPR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016020 (100%),membrane (100%),GO:0008137 (100%);GO:0051539 (100%),NADH dehydrogenase (ubiquinone) activity (100%);4 iron, 4 sulfur cluster binding (100%),GO:0042773 (100%),ATP synthesis coupled electron transport (100%),IPR000283 (100%);IPR001041 (100%);IPR006656 (100%),NADH:ubiquinone oxidoreductase, 75kDa subunit, conserved site (100%);2Fe-2S ferredoxin-type iron-sulfur binding domain (100%);Molybdopterin oxidoreductase (100%)
AEFVEVTK,Bovinae,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,Laurasiatheria,Artiodactyla,Ruminantia,Pecora,,Bovidae,Bovinae,,,,,,,,,,,,,,,GO:0005615 (81%);GO:0032991 (25%);GO:0005783 (19%),extracellular space (81%);protein-containing complex (25%);endoplasmic reticulum (19%),GO:0046872 (69%);GO:0003677 (25%);GO:0005504 (25%),metal ion binding (69%);DNA binding (25%);fatty acid binding (25%),GO:0009267 (25%);GO:0043066 (25%);GO:0051659 (25%),cellular response to starvation (25%);negative regulation of apoptotic process (25%);maintenance of mitochondrion location (25%),IPR000264 (100%);IPR014760 (100%);IPR020857 (100%),ALB/AFP/VDB (100%);Serum albumin, N-terminal (100%);Serum albumin, conserved site (100%)
LSGTAANTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGEHNLDVLEGNE,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGEHNLDVL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVPALFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005730 (50%),nucleolus (50%),GO:0003723 (100%);GO:0008757 (50%);GO:0016779 (50%),RNA binding (100%);S-adenosylmethionine-dependent methyltransferase activity (50%);nucleotidyltransferase activity (50%),GO:0006396 (100%);GO:0001510 (50%);GO:0042254 (50%),RNA processing (100%);RNA methylation (50%);ribosome biogenesis (50%),IPR001678 (50%);IPR002646 (50%);IPR003607 (50%),SAM-dependent methyltransferase RsmB/NOP2-type (50%);Poly A polymerase, head domain (50%);HD/PDEase domain (50%)
VVVTLSPR,Hypsibius dujardini,Eukaryota,Metazoa,,,Tardigrada,,,Eutardigrada,,,Parachela,,,Hypsibioidea,Hypsibiidae,,,,Hypsibius,,,,Hypsibius dujardini,,,,,,,,,,GO:0005524 (100%);GO:0016887 (100%),ATP binding (100%);ATPase (100%),,,IPR003593 (100%);IPR003959 (100%);IPR027417 (100%),AAA+ ATPase domain (100%);ATPase, AAA-type, core (100%);P-loop containing nucleoside triphosphate hydrolase (100%)
HVELLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.- (29%);2.4.1.1 (20%);3.6.-.- (14%),In phosphorus-containing anhydrides (29%);Glycogen phosphorylase (20%);Acting on acid anhydrides (14%),GO:0005737 (25%);GO:0016021 (12%);GO:0005886 (2%),cytoplasm (25%);integral component of membrane (12%);plasma membrane (2%),GO:0046872 (28%);GO:0003677 (20%);GO:0005525 (17%),metal ion binding (28%);DNA binding (20%);GTP binding (17%),GO:0042274 (11%);GO:0005975 (7%);GO:0006400 (5%),ribosomal small subunit biogenesis (11%);carbohydrate metabolic process (7%);tRNA modification (5%),IPR027417 (20%);IPR009057 (15%);IPR001647 (15%),P-loop containing nucleoside triphosphate hydrolase (20%);Homeobox-like domain superfamily (15%);DNA-binding HTH domain, TetR-type (15%)
YGLVGEVK,Xanthomonadaceae,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,Xanthomonadales,,,,Xanthomonadaceae,,,,,,,,,,,,,,2.7.2.8 (100%),Acetylglutamate kinase (100%),GO:0005737 (100%),cytoplasm (100%),GO:0003991 (100%);GO:0005524 (100%),acetylglutamate kinase activity (100%);ATP binding (100%),GO:0006526 (100%),arginine biosynthetic process (100%),IPR001048 (100%);IPR004662 (100%);IPR006855 (100%),Aspartate/glutamate/uridylate kinase (100%);Acetylglutamate kinase family (100%);Vertebrate-like NAGS Gcn5-related N-acetyltransferase (GNAT) domain (100%)
SSPATLNSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELYTLEQELAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGEHNLDVLE,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AVLHEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.104 (74%);3.6.4.12 (4%);6.1.1.3 (3%),Cyanase (74%);DNA helicase (4%);Threonine--tRNA ligase (3%),GO:0016021 (13%);GO:0005737 (7%);GO:0005815 (4%),integral component of membrane (13%);cytoplasm (7%);microtubule organizing center (4%),GO:0003677 (51%);GO:0008824 (48%);GO:0005524 (11%),DNA binding (51%);cyanate hydratase activity (48%);ATP binding (11%),GO:0009439 (48%);GO:0007165 (4%);GO:0006355 (3%),cyanate metabolic process (48%);signal transduction (4%);regulation of transcription, DNA-templated (3%),IPR003712 (44%);IPR036581 (44%);IPR008076 (43%),Cyanate lyase, C-terminal (44%);Cyanate lyase, C-terminal domain superfamily (44%);Cyanate hydratase (43%)
TAALTACR,Achromobacter,Bacteria,,,,Proteobacteria,,,Betaproteobacteria,,,Burkholderiales,,,,Alcaligenaceae,,,,Achromobacter,,,,,,,,,,,,,,GO:0003676 (100%);GO:0004519 (100%),nucleic acid binding (100%);endonuclease activity (100%),,,IPR002711 (100%);IPR003615 (100%),HNH endonuclease (100%);HNH nuclease (100%)
SHYAATK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.4.2 (67%);7.2.2.14 (33%),Glycine dehydrogenase (aminomethyl-transferring) (67%);P-type Mg(2+) transporter (33%),GO:0005886 (25%);GO:0016021 (25%),plasma membrane (25%);integral component of membrane (25%),GO:0004375 (50%);GO:0003854 (25%);GO:0005524 (25%),glycine dehydrogenase (decarboxylating) activity (50%);3-beta-hydroxy-delta5-steroid dehydrogenase activity (25%);ATP binding (25%),GO:0009116 (50%);GO:0006546 (25%);GO:0006694 (25%),nucleoside metabolic process (50%);glycine catabolic process (25%);steroid biosynthetic process (25%),IPR036291 (85%);IPR002347 (80%);IPR015421 (10%),NAD(P)-binding domain superfamily (85%);Short-chain dehydrogenase/reductase SDR (80%);Pyridoxal phosphate-dependent transferase, major domain (10%)
AGLLHFTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.100 (100%),3-oxoacyl-[acyl-carrier-protein] reductase (100%),,,GO:0016491 (99%);GO:0004316 (1%);GO:0102131 (1%),oxidoreductase activity (99%);3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity (1%);3-oxo-glutaryl-[acp] methyl ester reductase activity (1%),,,IPR002347 (100%);IPR036291 (100%);IPR020904 (96%),Short-chain dehydrogenase/reductase SDR (100%);NAD(P)-binding domain superfamily (100%);Short-chain dehydrogenase/reductase, conserved site (96%)
ALFVLGLNEK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (100%),DNA helicase (100%),,,GO:0003677 (100%);GO:0003678 (100%);GO:0005524 (100%),DNA binding (100%);DNA helicase activity (100%);ATP binding (100%),,,IPR027417 (100%);IPR038726 (89%);IPR000212 (37%),P-loop containing nucleoside triphosphate hydrolase (100%);PD-(D/E)XK endonuclease-like domain, AddAB-type (89%);DNA helicase, UvrD/REP type (37%)
LTVLALHDN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TPFGLSLQALQQQLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GLGLTAHLTTGQAG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SCLLSGWGN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGLAPGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.99.18 (100%);6.1.1.- (0%);2.1.1.163 (0%),DNA-(apurinic or apyrimidinic site) lyase (100%);Ligases forming aminoacyl-tRNA and related compounds (0%);Demethylmenaquinone methyltransferase (0%),GO:0016021 (0%);GO:0005634 (0%);GO:0005886 (0%),integral component of membrane (0%);nucleus (0%);plasma membrane (0%),GO:0003677 (99%);GO:0051539 (99%);GO:0004519 (98%),DNA binding (99%);4 iron, 4 sulfur cluster binding (99%);endonuclease activity (98%),GO:0006284 (98%);GO:0006281 (2%);GO:0006285 (0%),base-excision repair (98%);DNA repair (2%);base-excision repair, AP site formation (0%),IPR011257 (100%);IPR023170 (100%);IPR003265 (99%),DNA glycosylase (100%);Helix-hairpin-helix, base-excision DNA repair, C-terminal (100%);HhH-GPD domain (99%)
VGPFAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.23 (87%);2.3.1.157 (87%);2.7.7.7 (4%),UDP-N-acetylglucosamine diphosphorylase (87%);Glucosamine-1-phosphate N-acetyltransferase (87%);DNA-directed DNA polymerase (4%),GO:0005737 (39%);GO:0016021 (13%);GO:0009360 (4%),cytoplasm (39%);integral component of membrane (13%);DNA polymerase III complex (4%),GO:0003977 (40%);GO:0019134 (40%);GO:0000287 (40%),UDP-N-acetylglucosamine diphosphorylase activity (40%);glucosamine-1-phosphate N-acetyltransferase activity (40%);magnesium ion binding (40%),GO:0006048 (40%);GO:0000902 (39%);GO:0009252 (39%),UDP-N-acetylglucosamine biosynthetic process (40%);cell morphogenesis (39%);peptidoglycan biosynthetic process (39%),IPR029044 (38%);IPR001451 (37%);IPR011004 (37%),Nucleotide-diphospho-sugar transferases (38%);Hexapeptide repeat (37%);Trimeric LpxA-like superfamily (37%)
AEVVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.10 (9%);3.2.1.86 (8%);2.7.13.3 (8%),Aminomethyltransferase (9%);6-phospho-beta-glucosidase (8%);Histidine kinase (8%),GO:0016021 (18%);GO:0005886 (6%);GO:0005737 (5%),integral component of membrane (18%);plasma membrane (6%);cytoplasm (5%),GO:0046872 (18%);GO:0005524 (14%);GO:0016616 (12%),metal ion binding (18%);ATP binding (14%);oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (12%),GO:0005975 (14%);GO:0006412 (5%);GO:0032259 (2%),carbohydrate metabolic process (14%);translation (5%);methylation (2%),IPR036291 (12%);IPR001088 (10%);IPR015955 (10%),NAD(P)-binding domain superfamily (12%);Glycoside hydrolase, family 4 (10%);Lactate dehydrogenase/glycoside hydrolase, family 4, C-terminal (10%)
LPFYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.10 (71%);5.1.1.7 (3%);3.2.1.23 (2%),Aminomethyltransferase (71%);Diaminopimelate epimerase (3%);Beta-galactosidase (2%),GO:0016021 (29%);GO:0005886 (6%);GO:0005737 (4%),integral component of membrane (29%);plasma membrane (6%);cytoplasm (4%),GO:0004047 (31%);GO:0008483 (31%);GO:0005524 (11%),aminomethyltransferase activity (31%);transaminase activity (31%);ATP binding (11%),GO:0019464 (29%);GO:0032259 (21%);GO:0006629 (8%),glycine decarboxylation via glycine cleavage system (29%);methylation (21%);lipid metabolic process (8%),IPR013977 (29%);IPR029043 (29%);IPR028896 (29%),Glycine cleavage T-protein, C-terminal barrel domain (29%);Glycine cleavage T-protein/YgfZ, C-terminal (29%);Aminomethyltransferase-like (29%)
LGEHNLD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NTFGGLSVQNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SGGPVVCNGQL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
KPQGPALALLQVVAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MEQATLHVPVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLLAMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.2.0 (14%);1.3.8.1 (10%);7.-.-.- (10%), (14%);Short-chain acyl-CoA dehydrogenase (10%);Translocases (10%),GO:0016021 (31%);GO:0005886 (6%);GO:0005737 (6%),integral component of membrane (31%);plasma membrane (6%);cytoplasm (6%),GO:0005524 (9%);GO:0003676 (8%);GO:0050660 (7%),ATP binding (9%);nucleic acid binding (8%);flavin adenine dinucleotide binding (7%),GO:0015074 (5%);GO:0003341 (4%);GO:0070286 (4%),DNA integration (5%);cilium movement (4%);axonemal dynein complex assembly (4%),IPR012337 (13%);IPR009057 (13%);IPR025959 (12%),Ribonuclease H-like superfamily (13%);Homeobox-like domain superfamily (13%);Winged helix-turn helix domain (12%)
APGPAAT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NSLLLAPMPTASTSQL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QFLANAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.3.1.24 (70%);1.1.1.267 (20%);2.7.1.2 (10%),Phosphoribosylanthranilate isomerase (70%);1-deoxy-D-xylulose-5-phosphate reductoisomerase (20%);Glucokinase (10%),GO:0005634 (17%);GO:0005737 (6%),nucleus (17%);cytoplasm (6%),GO:0004640 (39%);GO:0003677 (17%);GO:0016853 (11%),phosphoribosylanthranilate isomerase activity (39%);DNA binding (17%);isomerase activity (11%),GO:0000162 (39%);GO:0016114 (11%);GO:0019288 (11%),tryptophan biosynthetic process (39%);terpenoid biosynthetic process (11%);isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway (11%),IPR001240 (33%);IPR011060 (33%);IPR013785 (33%),N-(5'phosphoribosyl) anthranilate isomerase (PRAI) domain (33%);Ribulose-phosphate binding barrel (33%);Aldolase-type TIM barrel (33%)
VFLSSLTK,Puniceicoccaceae,Bacteria,,,,Verrucomicrobia,,,Opitutae,,,Puniceicoccales,,,,Puniceicoccaceae,,,,,,,,,,,,,,,,GO:0043190 (100%),ATP-binding cassette (ABC) transporter complex (100%),,,GO:0055085 (100%),transmembrane transport (100%),IPR000914 (100%);IPR030678 (100%);IPR039424 (100%),Solute-binding protein family 5 domain (100%);Peptide/nickel binding protein, MppA-type (100%);Solute-binding protein family 5 (100%)
QQVHLETER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GTLAGALR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (100%),DNA-directed RNA polymerase (100%),GO:0016021 (57%);GO:0005886 (29%);GO:0005741 (5%),integral component of membrane (57%);plasma membrane (29%);mitochondrial outer membrane (5%),GO:0004888 (24%);GO:0005524 (14%);GO:0003677 (10%),transmembrane signaling receptor activity (24%);ATP binding (14%);DNA binding (10%),GO:0055085 (33%);GO:0006935 (24%);GO:0007165 (24%),transmembrane transport (33%);chemotaxis (24%);signal transduction (24%),IPR000515 (27%);IPR035906 (27%);IPR003660 (23%),ABC transporter type 1, transmembrane domain MetI-like (27%);MetI-like superfamily (27%);HAMP domain (23%)
LTLSGGSFTATNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AASASELAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVLPHLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.14.14.5 (33%);3.1.3.3 (33%);3.1.26.3 (17%),Alkanesulfonate monooxygenase (33%);Phosphoserine phosphatase (33%);Ribonuclease III (17%),GO:0016021 (43%);GO:0005737 (7%);GO:0005886 (5%),integral component of membrane (43%);cytoplasm (7%);plasma membrane (5%),GO:0008168 (40%);GO:0016706 (40%);GO:0016705 (10%),methyltransferase activity (40%);2-oxoglutarate-dependent dioxygenase activity (40%);oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen (10%),GO:0006564 (5%);GO:0055085 (5%);GO:0002218 (2%),L-serine biosynthetic process (5%);transmembrane transport (5%);activation of innate immune response (2%),IPR000477 (32%);IPR015095 (30%);IPR043502 (30%),Reverse transcriptase domain (32%);Alkylated DNA repair protein AlkB, homologue 8, N-terminal (30%);DNA/RNA polymerase superfamily (30%)
HSYLHSHPQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVALEHAMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVLLAQAFAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPAVPPLPLCR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RPVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.11 (97%);2.3.1.20 (1%);2.3.3.14 (1%),3-methyl-2-oxobutanoate hydroxymethyltransferase (97%);Diacylglycerol O-acyltransferase (1%);Homocitrate synthase (1%),GO:0005737 (74%);GO:0016021 (2%);GO:0005886 (1%),cytoplasm (74%);integral component of membrane (2%);plasma membrane (1%),GO:0046872 (86%);GO:0003864 (74%);GO:0008168 (72%),metal ion binding (86%);3-methyl-2-oxobutanoate hydroxymethyltransferase activity (74%);methyltransferase activity (72%),GO:0015940 (74%);GO:0032259 (72%);GO:0045892 (4%),pantothenate biosynthetic process (74%);methylation (72%);negative regulation of transcription, DNA-templated (4%),IPR003700 (73%);IPR015813 (73%);IPR040442 (73%),Ketopantoate hydroxymethyltransferase (73%);Pyruvate/Phosphoenolpyruvate kinase-like domain superfamily (73%);Pyruvate kinase-like domain superfamily (73%)
FLATLPLGR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.100 (63%);1.1.1.47 (22%);1.2.1.62 (14%),3-oxoacyl-[acyl-carrier-protein] reductase (63%);Glucose 1-dehydrogenase (NAD(P)(+)) (22%);4-formylbenzenesulfonate dehydrogenase (14%),,,GO:0004316 (44%);GO:0102131 (44%);GO:0102132 (44%),3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity (44%);3-oxo-glutaryl-[acp] methyl ester reductase activity (44%);3-oxo-pimeloyl-[acp] methyl ester reductase activity (44%),GO:0019290 (1%),siderophore biosynthetic process (1%),IPR036291 (100%);IPR002347 (100%);IPR020904 (18%),NAD(P)-binding domain superfamily (100%);Short-chain dehydrogenase/reductase SDR (100%);Short-chain dehydrogenase/reductase, conserved site (18%)
ESVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.11.1 (20%);3.4.11.10 (20%);6.1.1.5 (5%),Leucyl aminopeptidase (20%);Bacterial leucyl aminopeptidase (20%);Isoleucine--tRNA ligase (5%),GO:0016021 (19%);GO:0005737 (14%);GO:0005886 (5%),integral component of membrane (19%);cytoplasm (14%);plasma membrane (5%),GO:0005524 (20%);GO:0003676 (8%);GO:0003677 (6%),ATP binding (20%);nucleic acid binding (8%);DNA binding (6%),GO:0006355 (2%);GO:0006817 (2%);GO:0006412 (2%),regulation of transcription, DNA-templated (2%);phosphate ion transport (2%);translation (2%),IPR027417 (14%);IPR014001 (6%);IPR001650 (6%),P-loop containing nucleoside triphosphate hydrolase (14%);Helicase superfamily 1/2, ATP-binding domain (6%);Helicase, C-terminal (6%)
LLQAAADAR,Nocardioides,Bacteria,,,,Actinobacteria,,,Actinomycetia,,,Propionibacteriales,,,,Nocardioidaceae,,,,Nocardioides,,,,,,,,,,,,,,,,,,IPR002589 (100%);IPR043472 (100%),Macro domain (100%);Macro domain-like (100%)
LHGLQQAK,Haliea,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,Cellvibrionales,,,,Halieaceae,,,,Haliea,,,,,,,,,,,,,,,,,,,
EGFAPESK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAPTLGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.20 (91%);6.1.1.2 (2%);1.1.1.37 (2%),Tryptophan synthase (91%);Tryptophan--tRNA ligase (2%);Malate dehydrogenase (2%),GO:0016021 (10%);GO:0005737 (2%);GO:0005886 (2%),integral component of membrane (10%);cytoplasm (2%);plasma membrane (2%),GO:0004834 (75%);GO:0016829 (4%);GO:0005524 (3%),tryptophan synthase activity (75%);lyase activity (4%);ATP binding (3%),GO:0009234 (4%);GO:0006436 (2%);GO:0005975 (1%),menaquinone biosynthetic process (4%);tryptophanyl-tRNA aminoacylation (2%);carbohydrate metabolic process (1%),IPR036052 (70%);IPR001926 (67%);IPR006654 (66%),Tryptophan synthase beta subunit-like PLP-dependent enzyme (70%);Pyridoxal-phosphate dependent enzyme (67%);Tryptophan synthase, beta chain (66%)
AGGMGLLSGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.2.13 (100%),Fructose-bisphosphate aldolase (100%),,,GO:0004332 (99%);GO:0016829 (1%);GO:0003824 (0%),fructose-bisphosphate aldolase activity (99%);lyase activity (1%);catalytic activity (0%),,,IPR002915 (100%);IPR013785 (99%);IPR041720 (97%),DeoC/FbaB/LacD aldolase (100%);Aldolase-type TIM barrel (99%);Aldolase FbaB-like, archaeal-type (97%)
GGATK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.6.1 (25%);3.2.1.14 (8%);2.4.1.117 (3%),Ribose-phosphate diphosphokinase (25%);Chitinase (8%);Dolichyl-phosphate beta-glucosyltransferase (3%),GO:0016021 (26%);GO:0005737 (7%);GO:0005634 (4%),integral component of membrane (26%);cytoplasm (7%);nucleus (4%),GO:0005524 (15%);GO:0003677 (8%);GO:0000287 (7%),ATP binding (15%);DNA binding (8%);magnesium ion binding (7%),GO:0009116 (6%);GO:0009165 (6%);GO:0009156 (5%),nucleoside metabolic process (6%);nucleotide biosynthetic process (6%);ribonucleoside monophosphate biosynthetic process (5%),IPR023346 (9%);IPR008565 (9%);IPR018537 (9%),Lysozyme-like domain superfamily (9%);Protein of unknown function DUF847 (9%);Peptidoglycan binding domain (9%)
YVGLVTVPASLF,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGVLPVSVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HTLPLLANVLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (100%),DNA-directed DNA polymerase (100%),GO:0005737 (100%);GO:0009360 (99%),cytoplasm (100%);DNA polymerase III complex (99%),GO:0003677 (100%);GO:0003887 (100%);GO:0008408 (99%),DNA binding (100%);DNA-directed DNA polymerase activity (100%);3'-5' exonuclease activity (99%),GO:0006260 (100%),DNA replication (100%),IPR022634 (100%);IPR001001 (100%);IPR022637 (98%),DNA polymerase III, beta sliding clamp, N-terminal (100%);DNA polymerase III, beta sliding clamp (100%);DNA polymerase III, beta sliding clamp, central (98%)
TLAPLTALR,Saccharopolyspora,Bacteria,,,,Actinobacteria,,,Actinomycetia,,,Pseudonocardiales,,,,Pseudonocardiaceae,,,,Saccharopolyspora,,,,,,,,,,,,,,GO:0016787 (100%),hydrolase activity (100%),,,IPR000064 (100%);IPR038765 (100%),Endopeptidase, NLPC/P60 domain (100%);Papain-like cysteine peptidase superfamily (100%)
GLAEQDQLAQESQGVLADR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSGSSYPSLLQC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLQYDAWGGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GDLVDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.2.2.10 (16%);4.2.1.46 (9%);2.8.1.13 (8%),P-type Ca(2+) transporter (16%);dTDP-glucose 4,6-dehydratase (9%);tRNA-uridine 2-sulfurtransferase (8%),GO:0016021 (19%);GO:0005737 (10%);GO:0009279 (4%),integral component of membrane (19%);cytoplasm (10%);cell outer membrane (4%),GO:0003677 (34%);GO:0005524 (15%);GO:0046872 (11%),DNA binding (34%);ATP binding (15%);metal ion binding (11%),GO:0000160 (27%);GO:0006355 (26%);GO:0009252 (4%),phosphorelay signal transduction system (27%);regulation of transcription, DNA-templated (26%);peptidoglycan biosynthetic process (4%),IPR036388 (25%);IPR001789 (25%);IPR011006 (25%),Winged helix-like DNA-binding domain superfamily (25%);Signal transduction response regulator, receiver domain (25%);CheY-like superfamily (25%)
LEGTAVPDGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,